2011 annual financial data
Neuphoria Therapeutics 2011 Operating cash flow margin
Direct answer
Operating cash flow margin was -232.06%.
Operating income was -10,482,121 USD and net income was -9,999,889 USD.
Operating cash flow was -7,895,000 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,402,068 USD
- Operating income
- -10,482,121 USD
- Net income
- -9,999,889 USD
- Operating cash flow
- -7,895,000 USD